Literature DB >> 6853486

Metabolic fate of platelet-activating factor in neutrophils.

F H Chilton, J T O'Flaherty, J M Ellis, C L Swendsen, R L Wykle.   

Abstract

1-O-[3H]Alkyl-2-acetyl-sn-glycero-3-phosphocholine (1-O-[3H]alkyl-2-acetyl-GPC) incubated with rabbit polymorphonuclear leukocytes was metabolized to 1-O-alkyl-2-acyl-GPC containing long chain groups at the 2 position. Within 5 min, 60% of the total label added to the cell suspension was found in the 1-O-[3H]alkyl-2-acyl-GPC. At earlier time points, 1-O-[3H]alkyl-2-lyso-GPC was present. No metabolites were detected that would indicate the ether bond had been cleaved or the polar head group had been altered by the cells. At subaggregating and subdegranulating concentrations of labeled 1-O-[3H]alkyl-2-acyl-GPC, the same pattern of product formation was observed. Furthermore, when 1-O-[3H]alkyl-2-lyso-GPC was added to the cells, it was taken up and acylated in the same manner as that from 1-O-alkyl-2-acetyl-GPC. The nature of the long chain acyl residues incorporated into the 2 position was then examined by argentation chromatography and high performance liquid chromatography. Argentation chromatography of 1-O-[3H]alkyl-2-acyl-3-acetylglycerols obtained from 1-O-[3H]alkyl-2-acyl-GPC after acetolysis indicated that mono-, di-, and tetraenoic fatty acids were the predominant molecular species being incorporated into the 2 position of the molecule (18, 55, and 18%, respectively). Furthermore, high performance liquid chromatographic analysis using synthetic 1-O-alkyl-2-acyl-GPC standards indicated that three fatty acids, linoleic, arachidonic, and oleic (50, 15, and 12%, respectively), were the major chains being incorporated into the 1-O-hexadecyl-linked species. Analysis of 1-O-[3H]alkyl-2-acyl-GPC derived from exogenously added 1-O-[3H]alkyl-2-lyso-GPC revealed the same distribution of acyl groups linked to the 2 position. The findings are consistent with a pathway in which two enzymatic activities are responsible for the metabolism of exogenous platelet-activating factor in the rabbit neutrophils: one that hydrolyzes the acetyl residue (acetylhydrolase) and another that transfers a fatty acyl chain to the 1-O-alkyl-2-lyso-GPC formed (possibly acyl-CoA:1-O-alkyl-2-lyso-GPC acyltransferase). These events appear to play an important role in inactivating this potentially lethal phospholipid.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6853486

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Characterization of serum platelet-activating factor (PAF) acetylhydrolase. Correlation between deficiency of serum PAF acetylhydrolase and respiratory symptoms in asthmatic children.

Authors:  M Miwa; T Miyake; T Yamanaka; J Sugatani; Y Suzuki; S Sakata; Y Araki; M Matsumoto
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

2.  Platelet-activating factor modulates phospholipid acylation in human neutrophils.

Authors:  J S Tou
Journal:  Lipids       Date:  1987-05       Impact factor: 1.880

3.  Interaction of platelet-activating factor with cultured guinea pig tracheal epithelial cells.

Authors:  L Churchill; F H Chilton; D Proud
Journal:  Biochem J       Date:  1991-06-15       Impact factor: 3.857

4.  Platelet activating factor receptor antagonist improves survival and attenuates eicosanoid release in severe endotoxemia.

Authors:  J R Fletcher; A G DiSimone; M A Earnest
Journal:  Ann Surg       Date:  1990-03       Impact factor: 12.969

5.  Binding and metabolism of platelet-activating factor by human neutrophils.

Authors:  J T O'Flaherty; J R Surles; J Redman; D Jacobson; C Piantadosi; R L Wykle
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

6.  Arachidonyl transfer from diacyl phosphatidylcholine to ether phospholipids in rat platelets.

Authors:  O Colard; M Breton; G Bereziat
Journal:  Biochem J       Date:  1984-09-15       Impact factor: 3.857

7.  Human endothelial cells in culture produce platelet-activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) when stimulated with thrombin.

Authors:  S M Prescott; G A Zimmerman; T M McIntyre
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

8.  Platelet-activating factor: mediator of the third pathway of platelet aggregation? A study in three patients with deficient platelet-activating factor synthesis.

Authors:  A Sturk; M C Schaap; J W ten Cate; H S Heymans; R B Schutgens; H Przyrembel; P Borst
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

9.  Dynamics of platelet-activating-factor release and uptake in a human neutrophil suspension.

Authors:  M Cluzel; C A Rohde; D W MacGlashan; B J Undem; F H Chilton
Journal:  Biochem J       Date:  1991-09-01       Impact factor: 3.857

10.  Metabolism of platelet-activating factor (PAF; 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and lyso-PAF (1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine) by cultured rat Kupffer cells.

Authors:  W Chao; A Siafaka-Kapadai; D J Hanahan; M S Olson
Journal:  Biochem J       Date:  1989-07-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.